Investment
Features
FeesSafety
Academy
More
Pluang+

Compare UBC Medical Indonesia Tbk. (LABS) vs Multi Bintang Indonesia Tbk. (MLBI) Price & Performance

UBC Medical Indonesia Tbk.Trade
Multi Bintang Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

UBC Medical Indonesia Tbk. vs Multi Bintang Indonesia Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp165 (market cap 635.95B, 843K 24h volume), while Multi Bintang Indonesia Tbk. trades at Rp6,975 (market cap 14.85T, 42.2K 24h volume). The key difference: Multi Bintang Indonesia Tbk. is far larger — about 23.4× UBC Medical Indonesia Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (843K versus 42.2K). Which is the better fit depends on your goals.

LABSMLBI
Market Cap
635.95B14.85T
Volume
843K42.2K
Lot
8.43K422
Turnover
137.6M293.55M
Average Price
163.226,956.22
Value
137.6M293.55M
Indicative Equilibrium Price
1656,975
Indicative Equilibrium Volume
2461

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LABS
View details
MLBI
View details

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS

About Multi Bintang Indonesia Tbk.

PT Multi Bintang Indonesia Tbk (The Company) was established on June 3, 1929, based on notarial deed No. 8 of Tjeerd Dijkstra, notary public in Medan, under the name of NV Nederlandsch Indische Bierbrouwerijen. The Company is part of the Heineken Group, where the ultimate shareholder is Heineken N.V. (Heineken).

Read more on MLBI